The following table presents selected financial information with respect to the Company’s single operating segment for the three months ended March 31, 2026, and 2025:


	Three Months Ended
(in thousands)		March 31, 2026			March 31, 2025
Product revenue, net		$	116,357		$	88,183
Cost of goods sold		6,323			5,028

Gross margin		95		%	94		%
B-VEC		547			1,973

KB111		992			27

KB304		3			242
KB407		762			349
KB408		143			298
KB707		2,432			2,738
KB801		787			454
KB803		1,142			486





Other research programs		736			692

Other research and development costs (1)		7,787			6,997
Total research and development		15,331			14,256
Selling, general and administrative		41,014			32,647

Income from operations		$	53,689		$	36,252

Other income

Interest and other income, net		7,753			7,345
Income before income taxes		$	61,442		$	43,597
Income tax expense		(5,510)			(7,864)
Net income		$	55,932		$	35,733

(1)Includes stock-based compensation, other manufacturing expenses related to our product candidates and other unallocated expenses which largely relates to depreciation and other facilities and equipment related costs.